SCHEMBL6907648

SCHEMBL6907648

CC(=O)Oc1c2ccccc2c(OC(C)=O)c2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.63
HTT P42858 3/20 0.63
HSD17B10 Q99714 3/20 0.63
MAPT P10636 2/20 0.63
TP53 P04637 1/20 0.63
GAA P10253 1/20 0.63
BACE1 P56817 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
TSHR P16473 2/20 0.49
POLB P06746 1/20 0.49
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ABCB11 O95342 1/20 0.47
HPGD P15428 2/20 0.47
MAPK1 P28482 2/20 0.47
ELANE P08246 1/20 0.47
ESR1 P03372 1/20 0.47
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47
HMGB1 P09429 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29368738 1.00 KDM4E (0.63) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL11780453 0.93 KDM4E (0.61) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL6652743 0.91 KDM4E (0.61) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL13666895 0.89 KDM4E (0.62) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9430129 0.88 HTT (0.57) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL30434021 0.88 HTT (0.67) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL20398637 0.88 HTT (0.67) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9643280 0.87 ABCB11 (0.64) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9642040 0.85 ABCB11 (0.62) KDM4EHTTHSD17B10MAPTTP53
SCHEMBL9713872 0.85 KDM4E (0.59) KDM4EHTTHSD17B10MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4145045-A None JP disclosed
US-12065521-B2 Compound having polycyclic aromatic skeleton, and endoperoxide compound of same KAWASAKI KASEI CHEMICALS LTD. (JP) 2024-08-20 US disclosed
WO-2023238762-A1 METHOD FOR PRODUCING BLUE CURED FILM, BLUE PHOTOSENSITIVE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING SAME, AND DISPLAY DEVICE 株式会社DNPファインケミカル 2023-12-14 WO disclosed
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
WO-2023283915-A1 PHOTOSENSITIVE COMPOSITION, PHOTOSENSITIVE ELEMENT, AND METHOD OF PRODUCING WIRING BOARD SHOWA DENKO MATERIALS CO., LTD. (JP) 2023-01-19 WO disclosed
WO-2023284643-A1 PHOTOSENSITIVE COMPOSITION, PHOTOSENSITIVE ELEMENT, AND METHOD OF PRODUCING WIRING BOARD SHOWA DENKO MATERIALS CO., LTD. (JP) 2023-01-19 WO disclosed
US-20220127385-A1 COMPOUND HAVING POLYCYCLIC AROMATIC SKELETON, AND ENDOPEROXIDE COMPOUND OF SAME KAWASAKI KASEI CHEMICALS LTD. (JP) 2022-04-28 US disclosed
US-11149103-B2 Photopolymerization sensitizer composition and photopolymerizable composition comprising the same KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-10-19 US disclosed
CN-113454090-A Compound having polycyclic aromatic skeleton and endoperoxide compound thereof 川崎化成工业株式会社 2021-09-28 CN disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
US-20190119426-A1 PHOTOPOLYMERIZATION SENSITIZER COMPOSITION AND PHOTOPOLYMERIZABLE COMPOSITION COMPRISING THE SAME KAWASAKI KASEI CHEMICALS LTD. (JP) 2019-04-25 US disclosed
US-20180208689-A1 PHOTOPOLYMERIZABLE COMPOSITION KAWASAKI KASEI CHEMICALS LTD. (JP) 2018-07-26 US disclosed
CN-1266108-C Process for prepn. of carboxylic acid esters of 9, 10-dihydroxy RUETGERS CHEMICALS AG (DE) 2006-07-26 CN disclosed
CN-1519222-A Process for prepn. of carboxylic acid esters of 9, 10-dihydroxy 吕特哥斯化学股份公司 2004-08-11 CN disclosed
EP-1431268-A1 Process for the production of carboxylic acid esters of 9,10-dihydroxy anthracene RÜTGERS Chemicals AG (DE) 2004-06-23 EP disclosed
EP-0780356-B1 Method for preparing a solution of an alkali salt of anthrahydroquinone KAWASAKI KASEI CHEMICALS (JP) 2000-08-23 EP disclosed
US-5750743-A Method for preparing a solution of an alkali salt of anthrahydroquinone KAWASAKI KASEI CHEMICALS LTD. (JP) 1998-05-12 US disclosed
EP-0780356-A2 Method for preparing a solution of an alkali salt of anthrahydroquinone KAWASAKI KASEI CHEMICALS LTD. (JP) 1997-06-25 EP disclosed
US-5347040-A Sensitized onium salts E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-09-13 US disclosed
JP-H04145045-A PRODUCTION OF ANTHRACENE DERIVATIVE MITSUBISHI PAPER MILLS LTD 1992-05-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC KDM4E 1028/4885HTT 1452/4885HSD17B10 2197/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC KDM4E 1028/4885HTT 1452/4885HSD17B10 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.